Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

MLA

Lin, Ming V., et al. “Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.” PLoS ONE, vol. 11, no. 7, July 2016, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0158431.

APA

Lin, M. V., Sise, M. E., Pavlakis, M., Amundsen, B. M., Chute, D., Rutherford, A. E., Chung, R. T., Curry, M. P., Hanifi, J. M., Gabardi, S., Chandraker, A., Heher, E. C., Elias, N., & Riella, L. V. (2016). Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS ONE, 11(7), 1–14. https://doi.org/10.1371/journal.pone.0158431

Chicago

Lin, Ming V., Meghan E. Sise, Martha Pavlakis, Beth M. Amundsen, Donald Chute, Anna E. Rutherford, Raymond T. Chung, et al. 2016. “Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.” PLoS ONE 11 (7): 1–14. doi:10.1371/journal.pone.0158431.